As of 2026-01-06, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 16.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.78 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -55.0%.
The range of the Relative Valuation is 10.01 - 25.12 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 30.6x | 29.3x |
| Forward P/E multiples | 21.6x - 36.1x | 26.9x |
| Fair Price | 10.01 - 25.12 | 16.11 |
| Upside | -72.0% - -29.8% | -55.0% |
| Date | P/E |
| 2026-01-05 | 75.81 |
| 2026-01-02 | 82.86 |
| 2025-12-31 | 75.49 |
| 2025-12-30 | 152.27 |
| 2025-12-29 | 173.15 |
| 2025-12-26 | 179.29 |
| 2025-12-24 | 181.32 |
| 2025-12-23 | 177.85 |
| 2025-12-22 | 184.62 |
| 2025-12-19 | 181.69 |
| 2025-12-18 | 176.88 |
| 2025-12-17 | 178.48 |
| 2025-12-16 | 175.97 |
| 2025-12-15 | 189.37 |
| 2025-12-12 | 190.87 |
| 2025-12-11 | 189.00 |
| 2025-12-10 | 185.06 |
| 2025-12-09 | 180.37 |
| 2025-12-08 | 180.00 |
| 2025-12-05 | 186.78 |
| 2025-12-04 | 183.65 |
| 2025-12-03 | 181.50 |
| 2025-12-02 | 175.19 |
| 2025-12-01 | 173.06 |
| 2025-11-28 | 172.24 |
| 2025-11-26 | 173.10 |
| 2025-11-25 | 174.14 |
| 2025-11-24 | 168.57 |
| 2025-11-21 | 167.66 |
| 2025-11-20 | 162.80 |
| 2025-11-19 | 165.08 |
| 2025-11-18 | 162.93 |
| 2025-11-17 | 162.95 |
| 2025-11-14 | 163.86 |
| 2025-11-13 | 164.32 |
| 2025-11-12 | 170.04 |
| 2025-11-11 | 171.39 |
| 2025-11-10 | 163.75 |
| 2025-11-07 | 159.91 |
| 2025-11-06 | 158.48 |
| 2025-11-05 | 166.27 |
| 2025-11-04 | 154.23 |
| 2025-11-03 | 160.89 |
| 2025-10-31 | 159.37 |
| 2025-10-30 | 156.75 |
| 2025-10-29 | 156.29 |
| 2025-10-28 | 155.23 |
| 2025-10-27 | 157.40 |
| 2025-10-24 | 157.31 |
| 2025-10-23 | 158.31 |